Vaccine maker Moderna’s stock was declining on Monday following an insider’s sale of shares.
Noubar Afeyan, a co-founder of Moderna (ticker: MRNA) and a board member, sold 15,000 shares of Moderna worth a total of $1.65 million through Flagship Pioneering, a venture capital company he founded. This information was disclosed in a filing with the Securities and Exchange Commission on Friday.
Moderna’s stock experienced an 8.32% decrease on Monday, making it the worst performer in the S&P 500. Meanwhile, the S&P 500 itself had gained 0.3% by midday.
When individuals closely associated with a company begin selling their positions, it can be interpreted as a warning sign for investors.
2023-09-18 13:10:24
Source from www.barrons.com
rnrn